BW-723C86 is an orally active, selective 5-HT2B receptor agonist used in preclinical research to study serotonin-mediated effects. It has demonstrated anxiolytic-like activity and alters feeding, grooming, pulmonary, and gastric responses in animal models. The compound is supplied as a high-purity solid for laboratory use.
- Selective 5-HT2B receptor agonist for receptor pharmacology studies.
- Orally active, suitable for in vivo administration in animal models.
- Reported anxiolytic-like and feeding-modulatory effects in preclinical assays.
- High purity (~99.8%) appropriate for research applications.
- Provided as a solid in small pack sizes for preclinical experiments.
- Defined molecular formula and CAS number for unambiguous identification.